The page lists 203 projects related to the topic "lung".
# | |||
---|---|---|---|
1 | ALEC | Aging Lungs in European Cohorts | 2015 |
2 | BeyondSeq | Genomic diagnostics beyond the sequence | 2015 |
3 | LuMaSense | A Non-Invasive Test for Guiding Follow–up of Patients with CT-Detected Lung Nodules | 2015 |
4 | BREATHE | Biochemically modified messenger RNA encoding nucleases for in vivo gene correction of severe inherited lung diseases | 2015 |
5 | A CACTUS | Antibody-free method for Counting All Circulating TUmour cellS while maintaining them alive and intact | 2015 |
6 | Muscle stress relief | Muscle Stress Relief: An integrated research program linking together basic research on secondary myopathies in stress states to innovative translation in applied myology. | 2016 |
7 | MobiliSense | Air pollution and noise exposure related to personal transport behaviour: short-term and longer-term effects on health | 2015 |
8 | ENABLE | Establishment of a Neutrophil elastase Activity home test for the Better management and treatment of Lung Exacerbations | 2014 |
9 | BMEVLP | Biomarkers for clinical assessment of lungs intended for transplantation | 2014 |
10 | FIBERSTAR | FIBER-optic sensors for Smart Thermal Ablation at Radiofrequency | 2016 |
11 | Brain Metastases | The Role of Circulating Monocytes in the Development of Brain Metastases | 2015 |
12 | Cdc42Adhere | Role of Cdc42 in cancer cell adhesion to endothelial cells and platelets | 2015 |
13 | GDA in staphylococci | Gen Duplication and Amplification in Staphylococcal populations | 2016 |
14 | CELLETEST | Liquid Biopsy blood test in lung cancer diagnosis and monitoring: a next generation noninvasive tumor tracker device | 2015 |
15 | ImplantFreeSpine | World’s first complete motion-preservation 'Implant-less' surgical correction for Scoliosis | 2015 |
16 | RAIL | Radiomics of lung cancer (RAIL): non-invasive stratification of tumour heterogeneity for personalised cancer therapy | 2015 |
17 | SIME-LMT | Development of a digital diagnostics rapid Lung Maturity Test (LMT) for premature infants, to assist neonatologists in the diagnosis of Respiratory Distress Syndrome at birth | 2015 |
18 | proLungPlasma | Validation of a Lung Cancer Plasma Reflex Test Using Epigenetic Biomarker for Cancer Detection | 2015 |
19 | PULTAR | Delivery of PULmonary Therapeutics through TARgetted Delivery using Phononics | 2015 |
20 | platinDx | A test for predicting the efficacy of common platinum drugs enabling personalized chemotherapy for bladder cancer patients. | 2015 |
21 | LEONID | Lung cancEr fusiOn geNes: a new dIagnostic Device | 2015 |
22 | MetCAF | Uncovering the Role of Cancer Associated Fibroblasts in Facilitating Breast Cancer Metastasis | 2015 |
23 | Novel asthma therapy | Biocompatible nanoparticles for T cell targeted siRNA delivery as novel asthma therapy | 2015 |
24 | PERIF | Perivascular cells at the crossroads of inflammation, regeneration and fibrosis | 2015 |
25 | IL7sigNETure | IL-7/IL-7R signaling networks in health and malignancy | 2015 |
26 | FrEBT | Improving diagnostics of respiratory diseases and boosting the COMAC MEDICAL Ltd. competitiveness and growth by validation of fractional EBT biomarker through new method of measurement and device | 2015 |
27 | EPIGEN | EPIGEN: A New Predictive Response Test for Non Small Cells Lung Cancer Treatment | 2015 |
28 | iPROTECTION | Molecular mechanisms of induced protection against sepsis by DNA damage responses | 2015 |
29 | MYCOCHASSIS | Engineering of a minimal bacterial therapeutic chassis | 2015 |
30 | SLACC | Supplying lung adenocarcinoma cell lines to the cancer research community. | 2015 |
31 | TB and Tobacco | Tobacco cessation within TB programmes: A ‘real world’ solution for countries with dual burden of disease | 2015 |
32 | FRESH AIR | Free Respiratory Evaluation and Smoke-exposure reductionby primary Health cAre Integrated gRoups | 2015 |
33 | EU-ToxRisk | An Integrated European ‘Flagship’ Program Driving Mechanism-based Toxicity Testing and Risk Assessment for the 21st Century | 2016 |
34 | SEPCELL | Title of Proposal: Restoring the immune system homeostasis and organ function in severe community acquired pneumonia- induced sepsis through adipose derived allogeneic stem cells (SEPCELL Proje | 2015 |
35 | TackSHS | Tackling secondhand tobacco smoke and e-cigarette emissions: exposure assessment, novel interventions, impact on lung diseases and economic burden in diverse European populations. The TackSHS Project. | 2015 |
36 | SmokeFreeBrain | Multidisciplinary tools for improving the efficacy of public prevention measures against smoking | 2015 |
37 | EPICHECK | Detection of Various Cancer Types for Screening and Diagnosis through Blood Samples with Epigenetic Biomarkers Panels | 2015 |
38 | CANDLE | Cancer Diagnosis by Multiplex Protein Epitope Profiling | 2015 |
39 | Tomo-FPS | Tomosynthesis is a low-dose alternate to has CT already transformed Breast Imaging, our vision is to reduce the costs, further enhance sensitivity and reduce dose, and transform portability. | 2015 |
40 | ARVisS | Augmented Reality Vision for Surgery | 2015 |
41 | ImMoRiSt | Immune Monitoring for RIsk STratification in Solid Organ Transplant Recipients | 2016 |
42 | miRNA-DisEASY | microRNA biomarkers in an innovative biophotonic sensor kit for high-specific diagnosis | 2015 |
43 | EVA | EVA - patient ventilation beyond limits | 2015 |
44 | CRADL | Continuous Regional Analysis Device for neonate Lung | 2016 |
45 | PAIR | Physical Activity, Inflammation and Respiratory health: an integrative analysis of biological, behavioural and environmental determinants | 2016 |
46 | PULMO | PULMO: Population dynamics, trophic interactions, and human exploitation of a novel nutraceutical and pharmaceutical marine resource: the Mediterranean sea lung jellyfish, Rhizostoma pulmo . | 2016 |
47 | EVI1inCancer | Overcoming the epigenetic and therapeutic barrier of EVI1-overexpressing cancers | 2016 |
48 | RespMicroFlows | Unravelling respiratory microflows in silico and in vitro: novel paths for targeted pulmonary delivery in infants and young children | 2016 |
49 | MICRO-MACRO-ILC | Dissecting the human microbiota-macrophage-innate lymphoid cell crosstalk in the lung | 2016 |
50 | iGEMMdev | Development and Characterisation of New Immunogenic GEMMs of Lung Cancer | 2017 |
51 | PrecTherLSCC | Precision Therapies in Lung Squamous Cell Carcinoma | 2016 |
52 | RAC | Defining the Role of Antioxidants on Cancer progression and metastasis | 2016 |
53 | GENDER-CF | Gender-related differences in expression of microRNAs in cystic fibrosis | 2017 |
54 | BiominAB-3D | Revealing the composition and formation mechanism of carcinogenic asbestos bodies in human lungs | 2016 |
55 | EXACT | Identifying biomarkers of Exposure leading to Lung Cancer with Adductomics | 2016 |
56 | RESPIRE 3 | REspiratory Science Promoted by International Research Exchanges 3 | 2016 |
57 | iBILD | iBILD: Imaging Biomarker for Intelligent Lung Cancer Detection | 2016 |
58 | CF_struct | High-Resolution X-ray Structures of Full-Length Cystic Fibrosis Transmembrane Conductance Regulator | 2016 |
59 | MESO-JBIR-102 | Development of the aza-Prins reaction; synthesis and biological evaluation of JBIR-102 | 2016 |
60 | ANGIO-IMAGE | ANGIO-tracer for immuno-PET imaging: a stratification and monitoring tool for anti-angiogenesis treatment | 2016 |
61 | Niche Fibrosis | Identification of regulatory signals from vascular niche in alveolar regeneration and pulmonary fibrosis | 2016 |
62 | Tissue-Tregs | Novel approaches to determining the function of tissue-specific regulatory T cells | 2016 |
63 | RespeCT | Respiratory Disease Screening with Dark-Field Computed Tomography | 2016 |
64 | GBM-CPP | Developing an anti-Myc cell-penetrating peptide for cancer treatment | 2016 |
65 | in3 | An integrated interdisciplinary approach to animal-free chemical and nanomaterial safety assessment | 2017 |
66 | UWIT | UnderWater Information Technology (UWIT) | 2016 |
67 | TiMaScan | Recirculated tissue macrophages (TiMa) in blood: Novel approach to early diagnosis and treatment monitoring in oncology | 2016 |
68 | THERACAN | Novel therapeutic strategies to treat pancreatic and lung cancer | 2017 |
69 | BREATH | BREATH: Biomarkers for Respiratory diseases detected in Exhaled Air through a new Technological instrument for research and Healthcare markets. | 2016 |
70 | MUC2GO | THE ROLE OF MUCINS AND MUCUS IN THE DISEASES CYSTIC FIBROSIS, CELIAC DISEASE, AND ULCERATIVE COLITIS | 2016 |
71 | HYPOXIMMUNO | Tackling the Achilles Heel of Immunotherapy: Validating imaging biomarkers and targeting the immunological niche of tumour hypoxia | 2016 |
72 | LungCARD | Blood test for clinical therapy guidance of non-small cell lung cancer patients | 2017 |
73 | IMMUNOSABR | Clinical proof of concept through a randomised phase II study: a combination of immunotherapy and stereotactic ablative radiotherapy as a curative treatment for limited metastatic lung cancer | 2017 |
74 | PDClungSME1 | A therapeutic vaccine candidate for lung cancer based on an exclusive cell line of Plasmacytoid Dendritic Cells (PDC*line) | 2016 |
75 | Curtana | Patented small molecule therapeutics that target cancer stem cells for the treatment of glioblastoma and other brain cancers | 2017 |
76 | MULTIDET | Multiplex qPCR detection and chemical analysis towards multifunctional diagnosis | 2017 |
77 | EXCITING-CT | Excellent lung cancer imaging and tumour identification using next generation computed tomography | 2017 |
78 | SCALTIE | Single cell analysis of the lung tumour-immune ecosystem: Developing new tools for effective immunotherapy | 2017 |
79 | IVORIaN | RAS/C-RAF interaction: A new pharmacological target in Kras-driven lung cancer. | 2017 |
80 | TISSUENEU | Role of infiltrating neutrophils in tissue homeostasis | 2017 |
81 | Immunometabolomics | CD8+ T cell metabolism in anti-tumor response | 2017 |
82 | IB4SD-TRISTAN | Imaging Biomarkers (IBs) for Safer Drugs: Validation of Translational Imaging Methods in Drug Safety Assessment - Sofia ref.: 116106 | 2017 |
83 | RoNDBioCan | NLRP3 in cancer: Deciphering the role of NLRP3 in the DNA Damage response pathway | 2018 |
84 | IASIS | Integration and analysis of heterogeneous big data for precision medicine and suggested treatments for different types of patients | 2017 |
85 | ESCAPE_COPD | Elimination of Senescent Cells Approach for treatment of COPD | 2017 |
86 | CFZEBRA | Balancing the immune response in cystic fibrosis: using zebrafish models of infection and inflammation to uncover new therapeutic approaches | 2017 |
87 | INTUMORX | Elucidation of intratumoral heterogeneity in Kras-driven cancers | 2017 |
88 | CATCH-U-DNA | Capturing non-Amplified Tumor Circulating DNA with Ultrasound Hydrodynamics | 2017 |
89 | INDEX | Integrated nanoparticle isolation and detection system for complete on-chip analysis of exosomes | 2017 |
90 | HybridHeart | Development of the first fully biocompatible, soft actuated heart: combining in situ tissue engineering and soft robotics | 2017 |
91 | onCOMBINE | Towards evidence-based combinations of approved and novel cancer drugs | 2017 |
92 | OligoGpivotalCF | A pivotal phase IIb clinical trial of inhaled alginate oligosaccharide (OligoG) for cystic fibrosis | 2018 |
93 | TRIBAL | A TRranslational approach to Identify Biomarkers for Asthma and Lung function impairment | 2017 |
94 | TissueLymphoContexts | Tissue-resident Lymphocytes: Development and Function in “real-life” Contexts | 2018 |
95 | EpiCBiome | Development of an innovative Airway-on-Chip microbiome cell culture model to investigate host-microbiome interactions at the airway epithelial surface | 2018 |
96 | XHaLe | Hanover experimental lung research project | 2018 |
97 | PulseHaler | PulseHaler: Improving the Lives of COPD Patients | 2017 |
98 | MetaRegulation | Metabolic regulation of metastatic growth | 2018 |
99 | iaFRET | An amplified signal imaging software for prognosis of cancer enabling the evaluation of clinicalefficiency of personalised cancer treatments to an unprecedented level. | 2018 |
100 | ONALABS | Non-invasive smart wearable solution for continuous monitoring of physiological parameters and biomarkers for chronic patientswith cardiac and respiratory diseases from the neonate to the elderly | 2018 |
101 | ToCCaTa | Tailoring the functional Capacity of Cytotoxic T cells for future Therapies | 2018 |
102 | IMMUNOMARK | Omics integration for precision cancer immunotherapy | 2018 |
103 | IRONAGE | Iron as a driver of fibrosis and regeneration | 2018 |
104 | ALPHA-STEM | Advanced Laboratory Phantoms for Soft Tissues in Engineering and Medicine: ALPHA-STEM | 2018 |
105 | BREFMC2017 | Deciphering the function(s) of the C-type lectin DCIR/CLEC4A in tuberculosis | 2018 |
106 | PneumoCaTChER | The role of cell-to-cell variability in pneumococcal virulence and antibiotic resistance | 2018 |
107 | VALSL | Valorisation of splice-switching oligonucleotides for lung cancer therapy | 2018 |
108 | RadonACCURACY | Accuracy assessment of the annual average indoor radon concentration based on measurements of different duration | 2018 |
109 | Particle-bound ROS | Reactive Oxygen Species (ROS) in atmospheric aerosols: exploring formation, sources and dynamics of a new air pollution toxicity metric | 2018 |
110 | MECH-LoC | Mechanically tuned Lung-on-a-Chip device to model pathology and drug screening for lung disease | 2018 |
111 | Proteasome in cancer | Identification of the proteasome machinery targets in human cancer | 2018 |
112 | Spectro-Metrics | Advanced Data Mining Procedures Applied to Raman Spectroscopy Investigations of Interactions between Drugs and Cells. | 2018 |
113 | FIBROSIS | Fibroproliferative Invasive Fibroblasts in Idiopathic Pulmonary Fibrosis | 2018 |
114 | PNECtumor | Mechanisms regulating pulmonary neuroendocrine cell (PNEC) growth and tumorigenesis | 2019 |
115 | ProLung | The role of maternal microbiota in offspring lung development and function | 2019 |
116 | MAGIC | Magnification of Asthma by human memory Group 2 Innate lymphoid Cells | 2018 |
117 | HDAC6_GEMM | Development of a novel genetically engineered mouse model to study the role of HDAC6 in oncogenesis and metastasis of non-small cell lung cancer. | 2018 |
118 | HUMANITY | Human Lung Microbiota And Innate Immunity | 2019 |
119 | PATROLS | Physiologically Anchored Tools for Realistic nanOmateriaL hazard aSsessment | 2018 |
120 | VES4US | Extracellular vesicles from a natural source for tailor-made nanomaterials | 2018 |
121 | HOPE | Host Protective Engineering of Cancer Immunity by Targeting the Intracellular Immune Checkpoint NR2F6 | 2018 |
122 | AngioMature | Mechanisms of vascular maturation and quiescence during development, homeostasis and aging | 2018 |
123 | NovaTests | The first predictive test for radio-sensitivity. A step towards an improved and personalised radiation therapy cancer treatment. | 2018 |
124 | ASSYSt | A reliable CXCL4 biomarker assay to improve diagnosis and treatment of Systemic Sclerosis | 2018 |
125 | PAH-HOPE | New hope for the PAH patient: A Novel Therapeutic for Pulmonary Arterial Hypertension (PAH) | 2018 |
126 | MINAPATH | MINAPATH: A novel and unique method to diagnose and prevent diseases that are caused by exposure and accumulation of inorganic mineral dusts. | 2018 |
127 | A3BL | Airofit - Better Breathing, Better Life | 2018 |
128 | AbCURE_COPD | Antibody mediated clearance of senescent cells for treatment of COPD | 2018 |
129 | Simecos | A New Adjuvant Nutraceutical from the North Atlantic Ocean for Breast, Lung and Pancreatic Cancer Patients | 2018 |
130 | SYST-iMYC | Development of an effective and safe systemic Myc inhibitor for the treatment of multiple cancer types. | 2018 |
131 | EUROoC | Interdisciplinary training network for advancing Organ-on-a-chip technology in Europe | 2018 |
132 | CL-IO | Commercial feasibility of non-pathogenic Clostridium-Mediated Cancer Immunotherapy: leveraging the presence of tumour hypoxia & necrosis | 2018 |
133 | Lung EpiCheck | Blood Samples and DNA-an Innovative Technique for Lung Cancer Diagnostics | 2018 |
134 | EPI-X4Health | Therapeutic potential of optimized derivatives of an endogenous CXCR4 antagonist for the treatment of cancers and inflammatory diseases | 2018 |
135 | LIFT | Liquid Foam Therapy (LIFT) for Acute Respiratory Distress Syndrome (ARDS) | 2018 |
136 | IM-ID | Defining the intrinsic transcriptional programs and the microenvironmental signals tailoring lung Interstitial Macrophage IDentity | 2019 |
137 | CONQR | Translation and Commercialization of a QSOX1-inhibitory Antibody Targeting the Tumor Microenvironment in Breast Cancer | 2018 |
138 | BRuSH | Oral bacteria as determinants for respiratory health | 2019 |
139 | PYROTECH | Climate Positive Drying System for Coffee Industries using a highly disruptive Pyrolysis Technology | 2018 |
140 | ONCOBIOME | Gut OncoMicrobiome Signatures (GOMS) associated with cancer incidence, prognosis and prediction of treatment response. | 2019 |
141 | BETTER-B | BETTER TREATMENTS FOR BREATHLESSNESS IN PALLIATIVE AND END OF LIFE CARE | 2019 |
142 | NECESSITY | NEw Clinical Endpoints in primary Sjögren’s Syndrome: an Interventional Trial based on stratifYing patients | 2019 |
143 | MycoVAP | Bacterial chassis for treating ventilator-associated pneumonia (VAP) | 2019 |
144 | NoLiMiTs | Novel Lifesaving Magnetic Tentacles | 2019 |
145 | PHIVIDIAS | Preclinical Human In Vitro Drug Immune Response Analysis Platform | 2019 |
146 | WELMO | Wearable Electronics for Effective Lung Monitoring | 2019 |
147 | ReSpire | Respirable Advanced Therapeutics for Cystic Fibrosis & other Lung Diseases | 2019 |
148 | ENTRI | Enteric-nervous-system-mediated regulation of intestinal inflammation | 2019 |
149 | 3DBIOLUNG | Bioengineering lung tissue using extracellular matrix based 3D bioprinting | 2019 |
150 | EGM | A disruptive life-saving solution for early detection of lung edema in heart failure patients | 2019 |
151 | ECMO-BIOMARKER | Delivering ECMO-BIOMARKER – a ground-breaking ICT-enabled ECMO Biomarker system providing clinicians with bedside decision support for better care and reduced costs of severe ICU patients | 2019 |
152 | SECRETE-HF | SECRETED FACTORS IN CARDIAC REMODELING PROVOKE TUMORIGENESIS AND END ORGAN DAMAGE IN HEART FAILURE | 2019 |
153 | BrEXo-Apt | Non-invasive and accurate diagnosis and treatment of breast cancer. | 2019 |
154 | GlyCANswer | Decoding the Cancer Glycoproteome Driven Immune Response | 2019 |
155 | TRACERxTME | Constructing an evolutionary atlas of the immune landscape in lung cancer | 2019 |
156 | MetaTarGet | Targeting metabolic regulation in metastasis formation | 2019 |
157 | LUNG-BIM | Induction of B cell immunity in the lung mucosa | 2019 |
158 | META2 | METAbolism of bone METAstasis (META2): Metabolic interactions between disseminated breast cancer cells and osteoblast lineage cells drive bone metastases formation | 2019 |
159 | ARGONAUT | ARGONAUT: from the synthesis of gAnglioside tumouR antiGens to a platfOrm for caNcer Active immUnoTherapy | 2019 |
160 | AmnioticID | Understanding the identity of the amniotic fluid stem cells | 2019 |
161 | IMMUcan | Integrated IMMUnoprofiling of large adaptive CANcer patients cohorts | 2019 |
162 | TargetDUBs | Targeting ubiquitin processing in cancer and fibrosis: novel probes for the Ubiquitin Carboxy-Terminal Hydrolases | 2019 |
163 | OPTIMISE | Dissecting the molecular pathogenesis of Legionella spp. in human lung models | 2019 |
164 | CB-103 | First effective targeted therapy for T-cell acute lymphoblastic leukemia (T-ALL) and other NOTCH pathway driven cancers | 2019 |
165 | TUBE | Transport derived Ultrafines and the Brain Effects | 2019 |
166 | PROTEUS | Predicting Routes Of Tumour Evolution driven by Unstable genomes and Selection | 2019 |
167 | ISAC | International Study on Age-related disparity in Cancer patient survival | 2019 |
168 | RespiriNTM | Progress novel assets (one FIH start) for non-tubercular mycobacteria that may act synergistically with bedaquiline and cytochrome bc drugs | 2019 |
169 | SIMCARE | SImulation-assisted Minimally invasive CAncer tREatment using the gosmart environment | 2019 |
170 | Genetic Vaccine | Study the therapeutic and preventive potential of targeting oncogenic mutations with CRISPR-Cas9 technology | 2019 |
171 | PTOoC | Plug-n-Play Tool-kit of Organ-on-Chips | 2019 |
172 | EMPAtHy | Endothelial Cell Molecular and Metabolic Heterogeneity in Pulmonary Arterial Hypertension | 2019 |
173 | RESPIRE4 | REspiratory Science Promoted by International Research Exchanges 4 | 2020 |
174 | NEXIM | A Next-generation targeted immuno-oncology therapy | 2019 |
175 | Anti-L1CAM | Anti-L1CAM antibody: A novel efficacious immunotherapy for pancreatic and ovarian cancer patients | 2019 |
176 | RASImmune | Targeting RAS driven tumour immune evasion | 2019 |
177 | TK-NEO | Personalized Cancer Immunotherapy through DNA-EP vaccines | 2019 |
178 | FRAME | FRAME - tumor genome-based personalized anti-cancer vaccines off-the-shelf | 2019 |
179 | IL7RsignaTHER | Antibody-based IL-7R targeted therapies | 2020 |
180 | SiC-MOSFET | Gas Sensors for future Ultra Low NOx Emission Legislation – Euro 7 | 2019 |
181 | MYCure | Innovative cancer therapy through Myc inhibition: taking OMO-103 to market | 2019 |
182 | HIL PT System | A revolutionary, cost effective, ultra-compact proton therapy system for cancer treatment | 2019 |
183 | MCBD | MCBD (MULTI-CORE BIOPSY DEVICE) INNOVATIVE BIOPSY TECHNOLOGY FOR THE NEW ERA OF TARGETED MEDICINE | 2019 |
184 | LIGHT4LUNGS | Inhalable Aerosol Light Source for Controlling Drug-Resistant Bacterial Lung Infections | 2019 |
185 | ReDS | A disruptive, life-saving solution for home monitoring and management of lung fluid congestion in heart failure patients | 2019 |
186 | CLARIFY | Cancer Long Survivors Artificial Intelligence Follow Up | 2020 |
187 | KiCloud | Intelligent and serverless, cloud-based infrastructure for medical diagnostic devices | 2019 |
188 | Demos | Design Principles of Branching Morphogenesis | 2020 |
189 | RheoCare | Rheological Monitoring of Chronic Respiratory Diseases | 2019 |
190 | SMA-TB | A novel Stratified Medicine Algorithm to predict treatment responses to host-directed therapy in TB patients. | 2020 |
191 | 4-IN THE LUNG RUN | 4-IN THE LUNG RUN: towards INdividually tailored INvitations, screening INtervals, and INtegrated co-morbidity reducing strategies in lung cancer screening | 2020 |
192 | discovAIR | Discovering the cellular landscape of the airways and the lung | 2020 |
193 | MInfla-Tilc | Generation of therapeutic antibodies targeting type 2 Innate Lymphoid cells in asthma | 2020 |
194 | ENDOWAVE | ENDObronchial microWAVE Ablation for the minimally invasive treatment of lung cancer | 2019 |
195 | DRTB-HDT | STRATIFIED HOST-DIRECTED THERAPY FOR DRUG-RESISTANT TUBERCULOSIS: A RANDOMIZED CONTROLLED MULTI-CENTRE TRIAL | 2020 |
196 | EPOCHAL | Beyond seasonal suffering: Effects of Pollen on Cardiorespiratory Health and Allergies | 2020 |
197 | ADVOS | ADVanced Organ Support – Revolution in intensive care for treatment of multiple organ failure | 2019 |
198 | TESTIMONY | Tumor Endothelial Cells: Gatekeepers Of Anti-Tumor Immunity | 2020 |
199 | BESG | Bioengineered exosomes based approaches for the effective treatment of non-small cell lung cancer | 2020 |
200 | ICG68-PROG | Imaging of c-Met aberrant cancers with Gallium-68 chelators for positron emission tomography | 2020 |
201 | SIGNAL | Sensing Neuro-immune Activation in the Lung microenvironment | 2020 |
202 | HTS MALDI-TOF MDD | MALDI-TOF mass spectrometry metabolite screening assays for drug discovery in human disease | 2020 |
203 | MMAP-VEX | Measuring and Modelling Air Pollution Within Vehicles – Implications for daily EXposure and Human Health. | 2020 |